{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:03Z","timestamp":1772166183588,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The fourth round talent training plan of Qingpu District Health System","award":["QWJ2022-04"],"award-info":[{"award-number":["QWJ2022-04"]}]},{"name":"The fourth round talent training plan of Qingpu District Health System","award":["w2021-25"],"award-info":[{"award-number":["w2021-25"]}]},{"name":"The fourth round talent training plan of Qingpu District Health System","award":["QKY2022-12"],"award-info":[{"award-number":["QKY2022-12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare the prognostic value of tumor-infiltrating lymphocytes (TILs) and CD3\u2009+\u2009cells and CD20\u2009+\u2009cells between schistosomal colorectal cancer (SCRC) and non-schistosomal CRC (NSCRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although schistosomiasis has been basically eliminated, it has not been completely extinction in China, and occasional outbreaks occur in Europe recently. The role of immune cells in the immune microenvironment of SCRC and NSCRC is remaining obscure, and the inflammation-based prognostic systems of SCRC has rarely been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HE-stained sections of 349 colorectal cancer (CRC) tumors, which were completely resected, were evaluated for density of TILs. Meanwhile, we evaluated CD3\u2009+\u2009T lymphocytes and CD20\u2009+\u2009B lymphocytes by immunochemistry. The relationship of these infiltrating immune cells with clinicopathological features, including schistosomiasis, and clinical outcomes was evaluated, and the prognostic roles of TILs in SCRC and NSCRC were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Except for age (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), there were no significant differences between NSCRC and SCRC patients in clinicopathological features (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.0\n                      <jats:italic>5<\/jats:italic>\n                      ). Beside, the positive expression pattern of sTILs, iTILs, CD3, and CD20 between NSCRC and SCRC patients was also similar (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.0\n                      <jats:italic>5<\/jats:italic>\n                      ). In the whole cohort, sTILs and CD3 were defined as independent prognostic factors (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.031 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003, respectively). CD3 was an independent prognostic factor both in the NSCRC and SCRC set (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.045, respectively). Higher sTILs, CD3, and CD20 were correlated with less aggressive tumor characteristics in the whole cohort and in subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although CD3 was an independent prognostic factor for both NSCRC and SCRC set, there were no significant differences between SCRC and NSCRC patients in sTILs, CD3, CD20, and in other clinicopathological features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-02911-3","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T01:08:01Z","timestamp":1675213681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3\u2009+\u2009T cells between schistosomal and non-schistosomal colorectal cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Weixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dacheng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"2911_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-18616-6_3","volume":"1154","author":"PT LoVerde","year":"2019","unstructured":"LoVerde PT. Schistosomiasis. Adv Exp Med Biol. 2019;1154:45\u201370.","journal-title":"Adv Exp Med Biol"},{"key":"2911_CR2","first-page":"1044","volume":"37","author":"SZ Yu","year":"2016","unstructured":"Yu SZ. Schistosomiasis must be eradicated: a review of fighting schitosomiasis in Qingpu, Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37:1044\u20136.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2911_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/bs.apar.2016.02.004","volume":"92","author":"Y Yang","year":"2016","unstructured":"Yang Y, et al. Integrated control strategy of schistosomiasis in the people\u2019s republic of China: projects involving agriculture, water conservancy, forestry, sanitation and environmental modification. Adv Parasitol. 2016;92:237\u201368.","journal-title":"Adv Parasitol"},{"key":"2911_CR4","first-page":"669","volume":"29","author":"Z Li-Juan","year":"2017","unstructured":"Li-Juan Z, et al. Endemic status of schistosomiasis in People\u2019s Republic of China in 2016. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017;29:669\u201377.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"2911_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/457036b","volume":"457","author":"A Mantovani","year":"2009","unstructured":"Mantovani A. Cancer: inflaming metastasis. Nature. 2009;457:36\u20137.","journal-title":"Nature"},{"key":"2911_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2911_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2911_CR8","doi-asserted-by":"crossref","unstructured":"S. O. H, H. K. Hamid, S. O. Mekki, S. H. Suleiman, S. Z. Ibrahim, Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J. Surg. Oncol. 8, 68 (2010).","DOI":"10.1186\/1477-7819-8-68"},{"key":"2911_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2049-9957-3-6","volume":"3","author":"MG Chen","year":"2014","unstructured":"Chen MG. Assessment of morbidity due to Schistosoma japonicum infection in China. Infect Dis Poverty. 2014;3:6.","journal-title":"Infect Dis Poverty"},{"key":"2911_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12957-017-1217-1","volume":"15","author":"AM Herman","year":"2017","unstructured":"Herman AM, et al. Colorectal cancer in a patient with intestinal schistosomiasis: a case report from Kilimanjaro Christian Medical Center Northern Zone Tanzania. World J Surg Oncol. 2017;15:146.","journal-title":"World J Surg Oncol"},{"key":"2911_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","volume":"26","author":"B Gryseels","year":"2012","unstructured":"Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26:383\u201397.","journal-title":"Infect Dis Clin North Am"},{"key":"2911_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4269\/ajtmh.1998.58.248","volume":"58","author":"AR Willingham","year":"1998","unstructured":"Willingham AR, et al. Schistosoma japonicum in the pig: the host-parasite relationship as influenced by the intensity and duration of experimental infection. Am J Trop Med Hyg. 1998;58:248\u201356.","journal-title":"Am J Trop Med Hyg"},{"key":"2911_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12957-020-01925-5","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer. World J Surg Oncol. 2020;18:149.","journal-title":"World J Surg Oncol"},{"key":"2911_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jcp.39.6.585","volume":"39","author":"JR Jass","year":"1986","unstructured":"Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol. 1986;39:585\u20139.","journal-title":"J Clin Pathol"},{"key":"2911_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/bjc.1984.60","volume":"49","author":"JL Svennevig","year":"1984","unstructured":"Svennevig JL, Lunde OC, Holter J, Bjorgsvik D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer. 1984;49:375\u20137.","journal-title":"Br J Cancer"},{"key":"2911_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0959-8049(92)90134-N","volume":"28A","author":"S Aaltomaa","year":"1992","unstructured":"Aaltomaa S, et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992;28A:859\u201364.","journal-title":"Eur J Cancer"},{"key":"2911_CR17","doi-asserted-by":"publisher","first-page":"10669","DOI":"10.1158\/0008-5472.CAN-07-0539","volume":"67","author":"G Alexe","year":"2007","unstructured":"Alexe G, et al. High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Res. 2007;67:10669\u201376.","journal-title":"Cancer Res"},{"key":"2911_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","volume":"28","author":"C Denkert","year":"2010","unstructured":"Denkert C, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28:105\u201313.","journal-title":"J Clin Oncol"},{"key":"2911_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6","volume":"182","author":"KM Ropponen","year":"1997","unstructured":"Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182:318\u201324.","journal-title":"J Pathol"},{"key":"2911_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203\u201313.","journal-title":"N Engl J Med"},{"key":"2911_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-019-1621-9","volume":"17","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World J Surg Oncol. 2019;17:85.","journal-title":"World J Surg Oncol"},{"key":"2911_CR22","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"KI Al-Shibli","year":"2008","unstructured":"Al-Shibli KI, et al. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008;14:5220\u20137.","journal-title":"Clin Cancer Res"},{"key":"2911_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","volume":"108","author":"BS Nedergaard","year":"2008","unstructured":"Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Gynecol Oncol. 2008;108:106\u201311.","journal-title":"Gynecol Oncol"},{"key":"2911_CR24","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1158\/0008-5472.CAN-07-5206","volume":"68","author":"M Schmidt","year":"2008","unstructured":"Schmidt M, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68:5405\u201313.","journal-title":"Cancer Res"},{"key":"2911_CR25","first-page":"6505","volume":"34","author":"SH Lim","year":"2014","unstructured":"Lim SH, et al. Effect of neoadjuvant chemoradiation on tumor-infiltrating\/associated lymphocytes in locally advanced rectal cancers. Anticancer Res. 2014;34:6505\u201313.","journal-title":"Anticancer Res"},{"key":"2911_CR26","doi-asserted-by":"publisher","first-page":"e6412","DOI":"10.1371\/journal.pone.0006412","volume":"4","author":"K Milne","year":"2009","unstructured":"Milne K, et al. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE. 2009;4:e6412.","journal-title":"PLoS ONE"},{"key":"2911_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.humpath.2015.08.007","volume":"47","author":"VH Koelzer","year":"2016","unstructured":"Koelzer VH, Zlobec I, Lugli A. Tumor budding in colorectal cancer\u2013ready for diagnostic practice? Hum Pathol. 2016;47:4\u201319.","journal-title":"Hum Pathol"},{"key":"2911_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.humpath.2012.07.026","volume":"44","author":"M Horcic","year":"2013","unstructured":"Horcic M, et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol. 2013;44:697\u2013705.","journal-title":"Hum Pathol"},{"key":"2911_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26:259\u201371.","journal-title":"Ann Oncol"},{"key":"2911_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000092967","volume":"13","author":"A Yosry","year":"2006","unstructured":"Yosry A. Schistosomiasis and neoplasia. Contrib Microbiol. 2006;13:81\u2013100.","journal-title":"Contrib Microbiol"},{"key":"2911_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0027-5107(94)90247-X","volume":"305","author":"A Ishii","year":"1994","unstructured":"Ishii A, et al. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review Mutat Res. 1994;305:273\u201381.","journal-title":"A review Mutat Res"},{"key":"2911_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3892\/mmr.2013.1648","volume":"8","author":"C Ye","year":"2013","unstructured":"Ye C, et al. Endoscopic characteristics and causes of misdiagnosis of intestinal schistosomiasis. Mol Med Rep. 2013;8:1089\u201393.","journal-title":"Mol Med Rep"},{"key":"2911_CR33","unstructured":", Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7\u201314 June 1994. IARC Monogr Eval Carcinog Risks Hum 61, 1\u2013241 (1994)."},{"key":"2911_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","volume":"26","author":"B Gryseels","year":"2012","unstructured":"Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26:383\u201397.","journal-title":"Infect Dis Clin North Am"},{"key":"2911_CR35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1200\/JCO.2011.41.0902","volume":"31","author":"S Loi","year":"2013","unstructured":"Loi S, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02\u201398. J Clin Oncol. 2013;31:860\u20137.","journal-title":"J Clin Oncol"},{"key":"2911_CR36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","volume":"25","author":"S Loi","year":"2014","unstructured":"Loi S, et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol. 2014;25:1544\u201350.","journal-title":"Ann Oncol"},{"key":"2911_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000221","volume":"9","author":"RD Kovaiou","year":"2007","unstructured":"Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007;9:1\u201317.","journal-title":"Expert Rev Mol Med"},{"key":"2911_CR38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","volume":"29","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29:610\u20138.","journal-title":"J Clin Oncol"},{"key":"2911_CR39","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/jnci\/djp335","volume":"101","author":"RM Simon","year":"2009","unstructured":"Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2009;101:1446\u201352.","journal-title":"J Natl Cancer Inst"},{"key":"2911_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26:259\u201371.","journal-title":"Ann Oncol"},{"key":"2911_CR41","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/annonc\/mdu227","volume":"25","author":"G Curigliano","year":"2014","unstructured":"Curigliano G, Perez EA. Immunoscoring breast cancer: TILs remember what they target. Ann Oncol. 2014;25:1455\u20136.","journal-title":"Ann Oncol"},{"key":"2911_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ajcp\/aqz136","volume":"153","author":"S Jun","year":"2020","unstructured":"Jun S, et al. Prognostic significance of stromal and intraepithelial tumor-infiltrating lymphocytes in small intestinal adenocarcinoma. Am J Clin Pathol. 2020;153:105\u201318.","journal-title":"Am J Clin Pathol"},{"key":"2911_CR43","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","volume":"72","author":"G Erdag","year":"2012","unstructured":"Erdag G, et al. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res. 2012;72:1070\u201380.","journal-title":"Cancer Res"},{"key":"2911_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01533513","volume":"38","author":"CJ Punt","year":"1994","unstructured":"Punt CJ, et al. Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes. Cancer Immunol Immunother. 1994;38:225\u201332.","journal-title":"Cancer Immunol Immunother"},{"key":"2911_CR45","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol. 2010;185:4977\u201382.","journal-title":"J Immunol"},{"key":"2911_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11523-017-0481-x","volume":"12","author":"NJ Flynn","year":"2017","unstructured":"Flynn NJ, Somasundaram R, Arnold KM, Sims-Mourtada J. The multifaceted roles of b cells in solid tumors: emerging treatment opportunities. Target Oncol. 2017;12:139\u201352.","journal-title":"Target Oncol"},{"key":"2911_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4048\/jbc.2013.16.1.32","volume":"16","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Seo JY, Ahn JH, Ahn SH, Gong G. Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer. 2013;16:32\u20139.","journal-title":"J Breast Cancer"},{"key":"2911_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2172-11-19","volume":"11","author":"V Deschoolmeester","year":"2010","unstructured":"Deschoolmeester V, et al. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol. 2010;11:19.","journal-title":"BMC Immunol"},{"key":"2911_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/CMR.0000000000000164","volume":"25","author":"C Fortes","year":"2015","unstructured":"Fortes C, et al. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival. Melanoma Res. 2015;25:306\u201311.","journal-title":"Melanoma Res"},{"key":"2911_CR50","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/modpathol.2009.80","volume":"22","author":"D Tougeron","year":"2009","unstructured":"Tougeron D, et al. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol. 2009;22:1186\u201395.","journal-title":"Mod Pathol"},{"key":"2911_CR51","doi-asserted-by":"publisher","first-page":"19997","DOI":"10.1038\/s41598-019-56441-8","volume":"9","author":"S Edin","year":"2019","unstructured":"Edin S, et al. The prognostic importance of CD20(+) B lymphocytes in colorectal cancer and the relation to other immune cell subsets. Sci Rep. 2019;9:19997.","journal-title":"Sci Rep"},{"key":"2911_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11523-017-0481-x","volume":"12","author":"NJ Flynn","year":"2017","unstructured":"Flynn NJ, Somasundaram R, Arnold KM, Sims-Mourtada J. The multifaceted roles of b cells in solid tumors: emerging treatment opportunities. Target Oncol. 2017;12:139\u201352.","journal-title":"Target Oncol"},{"key":"2911_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tranon.2019.11.008","volume":"13","author":"F Perri","year":"2020","unstructured":"Perri F, et al. Immune response against head and neck cancer: biological mechanisms and implication on therapy. Transl Oncol. 2020;13:262\u201374.","journal-title":"Transl Oncol"},{"key":"2911_CR54","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ijc.32571","volume":"146","author":"C Zhou","year":"2020","unstructured":"Zhou C, et al. Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection. Int J Cancer. 2020;146:1152\u201363.","journal-title":"Int J Cancer"},{"key":"2911_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/jop.12698","volume":"47","author":"C Zhou","year":"2018","unstructured":"Zhou C, et al. Density and location of CD3(+) and CD8(+) tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma. J Oral Pathol Med. 2018;47:359\u201367.","journal-title":"J Oral Pathol Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-02911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-02911-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-02911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T10:10:03Z","timestamp":1675419003000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-02911-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2911"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-02911-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1931985\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of Fudan University, in accordance with the Helsinki Declaration of 1975. Prior written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}